PFSA
Profusa, Inc. Common Stock
NASDAQ · Healthcare · Medical - Equipment & Services · US
$2.72
+3.82%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
Market Cap
$1.65M
MomentumView details →
1D Return
+3.82%
YTD Return
−99.64%
RSI (14)
43.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
Market Cap
$1.65M
RSI (14)
43.3
MomentumView details →
1D Return
+3.82%
YTD Return
−99.64%
Similar companies
Latest newsMore news →
Profusa, Inc. issued a senior secured convertible promissory note to Ascent Partners Fund LLC, with a principal amount of $329,670.33 and a purchase price of $300,000, bearing 7% annual interest and convertible into common stock at $4.28 per share.3d agoProfusa, Inc. regained compliance with Nasdaq Rule 5550(a)(4) regarding minimum public float, as determined by Nasdaq on August 21, 2026.4d agoProfusa, Inc. amended its securities purchase agreement with Ascent Partners Fund LLC, adding a new note form and amending the exercise price of a previously issued warrant to $1.07 per share.15d ago